Two thirds of COVID-19 patients improve after Gilead drug
By Reuters / April 20, 2010 / marketsanity.com / Article Link
"We look forward to the results of controlled clinical trials to potentially validate these findings," wrote the paper's lead author and director of hospital epidemiology at Cedars-Sinai Medical